Hematology TimesIbrutinib sustains efficacy in CLL at 4-year follow-upNovember 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesIntervention improves well-being in AYAs with cancerNovember 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology NewsFDA approves first Erdheim-Chester disease treatmentNovember 6, 2017Myelodysplastic SyndromeRare DiseasesLeukemia, Myelodysplasia, Transplantation
Hematology NewsGenotype-guided warfarin dosing reduced adverse events in arthroplasty patientsNovember 6, 2017Thrombosis
Oncology PracticeNew persistent opioid use common after cancer surgeryNovember 6, 2017Patient & Survivor CareBreast CancerOpioid Resource Center
Hematology NewsYoung female hematologic cancer survivors have increased infertility riskNovember 6, 2017Hodgkin LymphomaPatient & Survivor Care
Hematology NewsSickle cell patients suffer discrimination, poor care – and shorter livesNovember 6, 2017Bleeding DisordersAnemia
Hematology TimesCancer drug costs increasing despite competitionNovember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLALLNon-Hodgkin Lymphoma
Oncology PracticePerioperative blood transfusion linked to worse outcomes in renal cell carcinomaNovember 5, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeWhite House opioid panel calls for more addiction specialistsNovember 5, 2017Practice ManagementOpioid Resource CenterBusiness of Medicine
Hematology TimesProduct can improve joint health in hemophilia ANovember 4, 2017ThrombosisBleeding Disorders
